Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Meets Nasdaq Trading Requirement

Premium

Rosetta Genomics last week said that it has regained compliance with the Nasdaq Stock Market's $1 minimum closing bid price requirement.

To satisfy the requirement, Rosetta's shares were required to achieve a closing price of at least $1 for 10 consecutive trading days.

As such, the company said that its shares will remain on the exchange.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.